Banca Farmafactoring S.p.A. Financials

Market Capitalization €1.46 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	5.93
Forward PE
Price to Sales TTM	€2.97
Price to Book MRQ	€1.73
Enterprise to Revenue	3.26
Enterprise to EBITDA

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	50.26%
Operating Margin	57.08%
Return on Assets TTM	1.99%
Return on Equity TTM	32.06%

Income Statement

Revenue TTM	€490,540,288
Revenue per Share TTM	€2.62
Quarterly Revenue Growth	-30.30%
Gross Profit TTM	€334,566,528
EBITDA	€0
Net Income to Common TTM	€246,535,600
Diluted EPS TTM	€1.31
Quarterly Earnings Growth YoY	-27.70%

Balance Sheet

Total Cash MRQ	€168,300,000
Total Cash per Share MRQ	€0.90
Total Debt MRQ	€
Total Debt to Equity MRQ	36.59
Current Ratio MRQ	1.08
Book Value per Share MRQ	€4.48

Cash Flow

Operating Cash Flow TTM	€167,800,745
Levered Free Cash Flow TTM	€171,661,757

2BF Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	187,900,000
Float Shares	177,514,141
Avg 10 Volume	249
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	5.75%
% Held by Institutions	49.51%

Stock Price Summary

Beta	0.80
Fifty Two Week Low	€7.21
Fifty Two Week High	€12.90
Fifty Two Week Change	-23.87%
Day 50 MA	€8.64
Day 200 MA	€9.47

Dividends and Splits

Forward Annual Dividend Rate	€1.08
Forward Annual Dividend Yield	13.59%
Trailing Annual Dividend Rate	€0.98
Trailing Annual Dividend Yield	12.30%
Payout Ratio	41.40%
Dividend Date
Ex Dividend Date	2024-04-22
Last Split Factor
Last Split Date